New Delhi: The global epidemic threatens to come to a new disaster amid the Coronavirus. These days the risk of a virus that is infecting children the most has increased. Cases of children suffering from severe respiratory infections are on the rise in UK hospitals. This includes an unseasonal increase in the infection called respiratory syncytial virus i.e. Respiratory Syncytial Virus (RSV) and has also been observed in two-month-olds. This is increasing the number of children admitted to the hospital for diseases such as bronchiolitis, which is similar to lung inflammation.
Why is the RSV commonly considered a cold disease growing in the summer of 2021? Restrictions imposed to prevent the spread of corona also prevented other respiratory viruses. Many respiratory diseases are spreading again in many countries due to the removal of these restrictions. RSV is a common respiratory germ and almost all of us are infected with it by the age of two years. Most people have mild symptoms of the disease, cold, runny nose, and cough. These symptoms usually heal without treatment in a week or two. About one in three children may have bronchiolitis due to RSV. This causes swelling in the respiratory tract and increases the temperature of patients, as well as making them breathing problems. Sometimes it becomes a very serious disease. If a young person starts having a lot of breathing problems, these symptoms can be severe, causing temperatures to cross 38 Celsius, blue lips, and extreme difficulty in breathing. Because of this disease in children, they may refuse to eat anything and do not urinate for a long time. One-month-old children need to be hospitalized because their trachea is too small.
Most cases can be controlled, but sometimes bronchiolitis becomes fatal. About 3.5 million children are hospitalized every year, and about five percent of them die. It seems that the corona caused significantly fewer people to get flu in the winter of 2020-21 due to washing hands, wearing masks, and reducing people-to-people contact. It's also true in terms of RSV. According to studies, the number of patients admitted to hospitals due to bronchiolitis in northern hemisphere countries was 83 percent lower than in previous years.
Like all infections, there must be a strong immunity in dealing with this disease. We know that 'neutralizing antibodies' protect against serious diseases. However, RSV does not last long, so most of us become infected again in our lives. That's why even after many attempts there is still no vaccine available. Some vaccines are being developed for this. A clinical trial of several vaccines is being conducted, which gives hope that we can protect our children from bronchiolitis caused by RSV.